However, the mechanisms undergirding insulin’s effect upon certain tumors have remained unclear, in part due to a lack of methods to assess tumor substrate preference and the impact of variations in hormones and substrates on tumor fuel preference. The gene discussed is INS; the disease is neoplasm.